Log In
Print this Print this

albuterol multi-dose dry-powder inhaler (MDPI)

  Manage Alerts
Collapse Summary General Information
Company Teva Pharmaceutical Industries Ltd.
DescriptionShort-acting adrenergic receptor beta 2 (ADRB2) agonist delivered via a breath-actuated, dry-powder inhaler.
Molecular Target Adrenergic receptor beta (ADRB)
Mechanism of ActionAdrenergic receptor beta (ADRB) agonist
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentRegistration
Standard Indication Pulmonary (unspecified)
Indication DetailsTreat and prevent bronchospasm in patients >=12 years old with reversible obstructive airway disease and to prevent exercise-induced bronchospasm in patients >=12 years old
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today